二甲双胍靶向胃癌干细胞
该研究在体外二维和三维培养及小鼠异种移植模型中评估二甲双胍对胃癌细胞系及患者来源原发肿瘤异种移植物的抗肿瘤作用。二甲双胍诱导细胞周期阻滞、减少肿瘤球数量并降低干细胞标志物表达,在体内延迟肿瘤生长并降低胃癌干细胞自我更新能力,提示其可能通过靶向胃癌干细胞抑制肿瘤生长。
要点
- 二甲双胍在二维培养中诱导细胞周期阻滞并减少细胞增殖。
- 二甲双胍在三维培养中减少肿瘤球数量,提示其靶向胃癌干细胞。
- 体内治疗患者来源异种移植物可延迟肿瘤生长并降低干细胞自我更新能力。
核心结论
- 研究结果提示使用二甲双胍可能通过靶向胃癌干细胞成为抑制肿瘤生长的有效策略。
研究设计与样本
- 研究在体外常规二维和三维培养系统及小鼠异种移植模型中评估二甲双胍对胃癌细胞系(MKN45、AGS和MKN74)及患者来源原发肿瘤异种移植物中胃癌干细胞的作用。
主要发现
- 二甲双胍在二维培养中诱导细胞周期阻滞,减少细胞增殖。
- 二甲双胍在三维培养系统中减少肿瘤球数量,揭示其靶向胃癌干细胞的能力。
- 二甲双胍降低干细胞标志物CD44和Sox2表达,升高分化标志物Kruppel样因子4和MUC5AC表达。
- 体内用二甲双胍治疗患者来源原发肿瘤异种移植物导致肿瘤生长延迟,并降低胃癌干细胞的自我更新能力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastric cancer is the third leading cause of cancer-related deaths worldwide and has still a poor prognosis. Therefore, new therapeutic strategies are needed: among them, targeting cancer stem cells (CSCs) could offer new opportunities. The aim of our study was to evaluate the anti-tumoural effect of metformin on gastric cancer in vitro and in vivo and especially, to determine whether this molecule could target the gastric CSCs. Metformin effects were evaluated on the proliferation and tumourigenic properties of the gastric CSCs from patient-derived primary tumour xenografts (PDXs) and cancer cell lines (MKN45, AGS and MKN74) in vitro in conventional 2 dimensional (2D) and in 3 dimensional (3D) culture systems, in which only CSCs are able to form tumourspheres and in mouse xenograft models in vivo. Metformin induced a cell cycle arrest, which decreased cell proliferation in the 2D cultures. In a 3D culture system, metformin decreased the number of tumourspheres, revealing its capacity to target the CSCs. This effect was confirmed by the study of the expression of CSC markers (CD44 and Sox2) and differentiation markers (Kruppel-like factor 4 and MUC5AC), which were decreased or increased in response to metformin, respectively. Finally, in vivo treatment of PDXs with metformin led to a tumour growth delay and decreased the self-renewal ability of the CSCs. These results suggest that the use of metformin could represent an efficient strategy to inhibit tumour growth by targeting gastric CSCs.
引用
- Courtois S, Durán RV, Giraud J, et al. Metformin targets gastric cancer stem cells. Eur J Cancer. 2017. PMID: 28822889. doi:10.1016/j.ejca.2017.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。